Skip to main content
logo
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.48
-0.15 (-1.74%)
Apr 2, 2026, 10:12 AM EDT - Market open

REGENXBIO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4387333837919821,401
Market Cap Growth
12.02%91.34%-51.56%-19.49%-29.88%-17.61%
Enterprise Value
465.08715.4247.84641.07795.191,162
Last Close Price
8.4814.407.7317.9522.6832.70
PE Ratio
--3.83-1.68-2.98-3.4911.24
Forward PE
-----76.17
PS Ratio
2.614.304.608.768.712.98
PB Ratio
4.287.131.482.541.901.83
P/TBV Ratio
4.267.231.472.521.901.88
P/FCF Ratio
--5.80-2.18-3.46-4.1210.40
P/OCF Ratio
--5.91-2.21-3.62-4.736.40
EV/Sales Ratio
2.734.202.977.107.052.47
EV/EBITDA Ratio
--4.91-1.14-2.56-3.186.85
EV/EBIT Ratio
--4.44-1.06-2.39-3.027.26
EV/FCF Ratio
--5.66-1.41-2.81-3.348.62
Debt / Equity Ratio
2.072.070.380.400.340.29
Debt / EBITDA Ratio
-1.79-1.79-0.65-0.73-0.931.52
Debt / FCF Ratio
-2.06-2.06-0.81-0.80-0.981.92
Net Debt / Equity Ratio
0.300.30-0.36-0.29-0.26-0.26
Net Debt / EBITDA Ratio
-0.21-0.210.430.370.53-1.18
Net Debt / FCF Ratio
-0.24-0.240.530.400.56-1.48
Asset Turnover
0.370.370.160.130.120.52
Quick Ratio
2.192.192.482.313.023.77
Current Ratio
2.382.382.692.573.193.98
Return on Equity (ROE)
-107.00%-107.00%-79.49%-63.65%-43.78%22.39%
Return on Assets (ROA)
-35.08%-35.08%-44.88%-38.09%-26.99%15.89%
Return on Invested Capital (ROIC)
-96.63%-96.63%-117.66%-86.33%-54.55%39.04%
Return on Capital Employed (ROCE)
-46.21%-46.21%-57.87%-46.77%-31.18%19.87%
Earnings Yield
-43.53%-26.11%-59.38%-33.54%-28.66%8.90%
FCF Yield
-28.37%-17.24%-45.84%-28.88%-24.26%9.62%
Buyback Yield / Dilution
-4.17%-4.17%-13.20%-1.35%1.73%-17.79%
Total Shareholder Return
-4.17%-4.17%-13.20%-1.35%1.73%-17.79%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q